Favorite Growth Pharma Play: Cramer

This is one of my absolute favorite growth phara names, said Cramer.

The Mad Money host was talking about Allergan.

"On the one hand, Allergan makes medicine. It's a leading player in the eye-care business, with treatments for everything from chronic dry-eye, to glaucoma, inflammation, infection, and allergies, as well as drugs in development for more severe conditions like diabetic macular edema," he said.

"On the other hand, though, Allergan's the number one medical aesthetics company, a purveyor of breast implants, eyelash enlargers, dermal fillers to smooth out your skin, and, of course, Botox."

And to make the stock all the more interesting, Cramer thinks treatments that were once only cosmetic may become something more.

"Botox doesn't just give you wrinkle-free skin. Allergan's been coming up with more and more ways to use this product—now it's a migraine treatment, and just last month the FDA approved Botox for idiopathic overactive bladder. And there are many more indications down the road, to the point where Allergan's Botox sales could double by 2020."

Allergan Inc.’s Botox
JB Reed | Bloomberg | Getty Images
Allergan Inc.’s Botox

And it's not just Botox.

"Allergan has a huge, diverse pipeline that should power the company's growth for years to come," Cramer said.

All told Cramer sees every reason for shares to rally. And in fact, over the past year, the stock has marched sharply higher, gaining about 25%

"I hope it comes down, I'd look to get in. But I don't know if you'll get a pullback with so many powerful catalysts ahead," said Cramer.

Read More from Cramer:
Are You Making Too Much Money?
Herculean Force to Drive Stock Market: Cramer
Energy Boom: Cramer ID's Stocks to Watch

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com